Field Of Vision
Copyright ©2012 Baishideng. All rights reserved.
World J Diabetes. Sep 15, 2012; 3(9): 158-160
Published online Sep 15, 2012. doi: 10.4239/wjd.v3.i9.158
Antidiabetic treatment: Though lovers be lost, love shall not
Nikolaos Papanas, Efstratios Maltezos
Nikolaos Papanas, Efstratios Maltezos, Outpatient Clinic of Obesity, Diabetes and Metabolism, Second Department of Internal Medicine, Democritus University of Thrace, Alexandroupolis 68100, Greece
Author contributions: Papanas N conceived and wrote the manuscript; Maltezos E finalised and provided useful insight throughout the process.
Correspondence to: Nikolaos Papanas, MD, Outpatient Clinic of Obesity, Diabetes and Metabolism, Second Department of Internal Medicine, Democritus University of Thrace, G Kondyli 22, Alexandroupolis 68100, Greece. papanasnikos@yahoo.gr
Telephone: +30-25-51084972 Fax: +30-25-51074723
Received: June 26, 2012
Revised: August 25, 2012
Accepted: September 5, 2012
Published online: September 15, 2012
Abstract

The new position statement of the American Diabetes Association and the European Association for the Study of Diabetes on the management of type 2 diabetes mellitus represents a paradigm shift in our understanding of antidiabetic treatment. It emphasises the necessity to individualise management based on patient needs. Glycaemic targets should also be pursued on an individualised basis. New therapeutic combinations are discussed, and the uncertainty surrounding the ideal choice is acknowledged. Above all, it is the mindful and experienced clinician who will implement the best available evidence towards flexible and efficacious treatment. Some areas of uncertainty may ensue, but it is expected that the new position statement will improve patient healthcare and treatment satisfaction. This now remains to be seen in practice.

Keywords: Diabetes mellitus; Guidelines; Insulin; Oral agents; Treatment